Related Experiment Video
Updated: Jun 16, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities
Robert Kleemann1, Richard Bucala
1Department of Biosciences, Gaubius Laboratory, TNO-Quality of Life, Zernikedreef 9, 2301 CE Leiden, The Netherlands. robert.kleemann@tno.nl
Abstract:
Obesity is associated with insulin resistance, disturbed glucose homeostasis, low grade inflammation, and comorbidities such as type 2 diabetes and cardiovascular disease. The cytokine macrophage migration inhibitory factor (MIF) is an ubiquitously expressed protein that plays a crucial role in many inflammatory and autoimmune disorders. Increasing evidence suggests that MIF also controls metabolic and inflammatory processes underlying the development of metabolic pathologies associated with obesity. This is a comprehensive summary of our current knowledge on the role of MIF in obesity and obesity-associated comorbidities, based on human clinical data as well as animal models of disease.

